Literature DB >> 20464810

Differential substance abuse patterns distribute according to gender in heroin addicts.

Icro Maremmani1, Canoniero Stefania, Matteo Pacini, Angelo G I Maremmani, Marina Carlini, Francesca Golia, Joseph Deltito, Liliana Dell'Osso.   

Abstract

This study attempts to analyse potential gender differences among a group of heroin addicts seeking treatment at a university-based medical centre. The central modality of treatment at this centre is the use of methadone maintenance. Among those patients entering this program there seems to be an emerging pattern of males who tend to use heroin as their opiate of choice, and are more likely to combine it with cannabis, while females are more likely to use to street methadone, with adjunctive use of ketamine, benzodiazepines, hypnotic drugs and/or amphetamines. Women are at higher risk of abusing opioids through a pathway of initial prescription painkiller use, and later to resort to street methadone to cope with prescription pain killer addiction. This latter pattern seems to result in an increased risk for fatal accidental overdoses. The use of these longer-acting agents in women may be influenced by psychosocial and hormonal factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464810     DOI: 10.1080/02791072.2010.10399789

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  12 in total

Review 1.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

2.  Impact of cannabis use during stabilization on methadone maintenance treatment.

Authors:  Jillian L Scavone; Robert C Sterling; Stephen P Weinstein; Elisabeth J Van Bockstaele
Journal:  Am J Addict       Date:  2013 Jul-Aug

3.  Gender differences in a clinical trial for prescription opioid dependence.

Authors:  R Kathryn McHugh; Elise E Devito; Dorian Dodd; Kathleen M Carroll; Jennifer Sharpe Potter; Shelly F Greenfield; Hilary Smith Connery; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2013-01-11

4.  Referrals and Treatment Completion for Prescription Opioid Admissions: Five Years of National Data.

Authors:  Barbara St Marie; Ethan Sahker; Stephan Arndt
Journal:  J Subst Abuse Treat       Date:  2015-07-26

5.  Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis.

Authors:  Jill B Becker; Adam N Perry; Christel Westenbroek
Journal:  Biol Sex Differ       Date:  2012-06-07       Impact factor: 5.027

Review 6.  Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors.

Authors:  Cynthia Wei-Sheng Lee; Ing-Kang Ho
Journal:  Mol Pain       Date:  2013-09-08       Impact factor: 3.395

7.  Methadone induces testosterone suppression in patients with opioid addiction.

Authors:  Monica Bawor; Brittany B Dennis; M Constantine Samaan; Carolyn Plater; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Meir Steiner; Rebecca Anglin; Margaret Coote; Guillaume Pare; Lehana Thabane; Zainab Samaan
Journal:  Sci Rep       Date:  2014-08-26       Impact factor: 4.379

8.  Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.

Authors:  Yao-Chang Chiang; Ruey-Yun Wang; Chieh-Liang Huang; Shue-Hwa Chen; Wen-Jing Ho; Hsien-Yuan Lane; Ing-Kang Ho; Hwei-Ting Yang; Wen-Lung Ma
Journal:  J Cell Mol Med       Date:  2017-07-12       Impact factor: 5.310

9.  Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol.

Authors:  Monica Bawor; Brittany B Dennis; Rebecca Anglin; Meir Steiner; Lehana Thabane; Zainab Samaan
Journal:  Syst Rev       Date:  2014-05-16

10.  Health-Related Quality of Life of Young Addict Women in Mashhad, IR Iran.

Authors:  Mohammad Khajedaluee; Reza Assadi; Maliheh Dadgar Moghadam
Journal:  Int J High Risk Behav Addict       Date:  2013-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.